Product Information

CLINDA-TRETINOIN 1.2%-0.025% is a generic product labeled by Oceanside Pharmaceuticals, priced at $4.3997 per GM under NDC 68682030030. Its NADAC has been published 177 times since May 18, 2022.

FDA first approved this application on Nov 7, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDA-TRETINOIN 1.2%-0.025%

clindamycin phosphate and tretinoin
$4.3997per GM

Strength

12; .25 mg/g; mg/g

NDC

68682030030

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

9/17/2025

Approval Type

Authorized Generic (NDA)

FDA Application

NDA050802

FDA Approved

11/7/2006

TE Code

AB1

On Market Since

8/4/2020

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade
Retinoid
Retinoids

Price Statistics

The NADAC for CLINDA-TRETINOIN 1.2%-0.025% has been published 177 times since May 18, 2022, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.

Current price$4.3997 per GM
All-time high$7.5670 (Oct 11, 2023)
All-time low$4.3997 (Sep 17, 2025)
52-week high$4.5311
52-week low$4.3997
Median price$5.9625
Average price$5.9432
Largest weekly change-31.8% (Dec 20, 2023)
Weeks tracked177
Tracking sinceMay 18, 2022

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

-2.9%

3Y

-41.9%

5Y

N/A

All

-26.2%

Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CLINDA-TRETINOIN 1.2%-0.025%?

The current National Average Drug Acquisition Cost (NADAC) for CLINDA-TRETINOIN 1.2%-0.025%, manufactured by Oceanside Pharmaceuticals, is $4.3997 per GM (NDC 68682030030), effective Oct 1, 2025.

How has the price of CLINDA-TRETINOIN 1.2%-0.025% changed over time?

Over the history we have for it, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has declined 26.2%. It has been tracked across 177 weekly CMS publications since May 18, 2022.

What are the highest and lowest recorded NADAC prices for CLINDA-TRETINOIN 1.2%-0.025%?

Since May 18, 2022, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has ranged from a low of $4.3997 (Sep 17, 2025) to a high of $7.5670 (Oct 11, 2023), with a median of $5.9625 per GM.

Are there cheaper alternatives to CLINDA-TRETINOIN 1.2%-0.025%?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDA-TRETINOIN 1.2%-0.025% in a comparable dosage form, but none are currently priced below it.

Who manufactures CLINDA-TRETINOIN 1.2%-0.025%?

CLINDA-TRETINOIN 1.2%-0.025% (NDC 68682030030) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.